Abstract
Background: Elevated plasma homocysteine level is an independent risk factor for cardiovascular disease. A common mutation (nucleotid 677C‐T) in the gene coding for methylenetetrahydrofolate reductase (MTHFR) has been reported to reduce the enzymatic activity of MTHFR and is associated with elevated plasma levels of homocysteine, especially in subjects with low folate intake.
Hypothesis: Methylenetetrahydrofolate reductase T/T genotype may be a risk factor for premature MI in Turkish population who are known to have low folate levels.
Methods: The study group was comprised of 96 men (aged < 45 years) with premature myocardial infarction (MI) and 100 age‐ and gender‐matched controls who had no history or clinical evidence of coronary artery disease (CAD) and/or MI. DNA was extracted from peripheral blood and genotypes were determined by polymerase chain reaction, restriction mapping with Hinfl, and gel electrophoresis. Conventional risk factors for CAD were prospectively documented.
Results: Allele and genotype frequencies among cases and control subjects were compatible with Hardy‐Weinberg equilibrium. The frequencies of T/T, C/T, and C/C genotypes among patients with MI and control subjects were 15.6,40.6, and 43.8%, and 5, 35, and 60%, respectively. Multivariate analyses identified smoking, MTHFR C/T polymorphism, diabetes mellitus, family history of CAD, and hypertension as the independent predictors of premature MI. Defining patients with non‐T/T genotype (C/C and C/T combined) as reference, the relative risk of MI for subjects with T/T genotype was 5.94 (95% confidence interval: 1.96–18.02, p = 0.0016).
Conclusions: Our findings suggest that C677T transition in the MTHFR gene may be a risk factor for premature MI in Turkish men.
Keywords: methylenetetrahydrofolate reductase gene, myocardial infarction
Full Text
The Full Text of this article is available as a PDF (393.4 KB).
References
- 1. Genest JJ, McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR: Plasma homocysteinemia levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114–1119 [DOI] [PubMed] [Google Scholar]
- 2. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877–881 [PubMed] [Google Scholar]
- 3. Mayer EL, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517–527 [DOI] [PubMed] [Google Scholar]
- 4. Daubner SC, Matthews RG: Purification and properties of methylenetetrahydrofolate reductase from pig liver. J Biol Chem 1982; 257: 140–145 [PubMed] [Google Scholar]
- 5. Goyette P, Summer JS, Milos R Duncan AM, Rosenblatt DS. Matthews RG, Rozen R: Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 1994; 7: 195–200 [DOI] [PubMed] [Google Scholar]
- 6. Frosst P, Blom HJ, Milos R Gotette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Hevvel LP: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113 [DOI] [PubMed] [Google Scholar]
- 7. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbel FJ, Blom HJ: Thermolabile 5,10 methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142–150 [PMC free article] [PubMed] [Google Scholar]
- 8. Jacques PF, Bostom AG, Williams RR Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R: Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 913: 7–9 [DOI] [PubMed] [Google Scholar]
- 9. Onat A, Senocak M: Relative risk of factors for coronary heart disease in a population with low cholesterol levels. Int J Cardiol 1994; 43: 51–60 [DOI] [PubMed] [Google Scholar]
- 10. Tokgozpglu SL, Alikasifoglu M, Unsal I, Atalar E, Aytemir K, Ozer N, Ovunc K, Usal O, Kes S, Tuncbilek E: Methylenetetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart 1999; 81: 518–522 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Gallagher PM, Meleady R, Shields DC, Tan S, Naughten E, Kraus JP, Sellar GC, Mc Connell, DJ, Graham I, Whitehead AS: Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Circulation 1996; 94: 2154–2158 [DOI] [PubMed] [Google Scholar]
- 12. Kang SS, Wong PW, Susmano A, Sora J, Norisis M, Ruggie N: Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536–545 [PMC free article] [PubMed] [Google Scholar]
- 13. Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M: Molecular variant of 5,10‐ methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 1996; 121: 293–294 [DOI] [PubMed] [Google Scholar]
- 14. Verhoef P, Rimm EB, Hunter DJ, Chen J, Willett WC, Kelsey K, Stampfer MJ: A common mutation in the methylenetetrahydrofolate reductase gene and risk of coronary heart disease: Results among U.S. men. J Am Coll Cardiol 1998; 32: 353–359 [DOI] [PubMed] [Google Scholar]
- 15. Narang R, Callahan G, Haider AW, Davies GJ, Tuddenham EG: Methylenetetrahydrofolate reductase mutation and coronary artery disease. Circulation 1996; 94: 2322–2323 [PubMed] [Google Scholar]
- 16. Kluijtmans LA, Van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oast BA, den Heijer M, Trijbels FJ, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Human Genet 1996; 58: 35–41 [PMC free article] [PubMed] [Google Scholar]
- 17. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamuno T, Ohno M, Yamaoki K. Ogasawara K, Aizawa T, Suziki S, Yazaki Y: Genetic polymorphism of 5,10 methylenetetrahydrofolate reductase as a risk factor for coronary artery disease. Circulation 1997; 95: 2032–2036 [DOI] [PubMed] [Google Scholar]
- 18. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R: Methylenetetrahydrofolate reductase poymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410–2416 [DOI] [PubMed] [Google Scholar]
- 19. Anderson JL, King GJ, Thomson MJ, Todd M, Bair TL, Muhlestein JB, Carlquist JF: A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 1997; 30: 1206–1211 [DOI] [PubMed] [Google Scholar]
- 20. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E: The 677 CT mutation of the MTHFR gene is not a risk factor for neural tube defects in the Turkish population. Arch Dis Child Fetal Neonatal Ed 1998; 78: F235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Tunçbilek E, Alikasifoglu M, Akdali B: Türkiye'dekonjenital malformasyon slkllgl, daglllml, risk faktörleri ve yenidoganlarin antropometik degerlendirmesi. Ankara: Tubitak Matbaasi, 1996. [Google Scholar]
- 22. Kluijtmans LA, Kastelein JP, Lindemans J, Boers GH, Heil SG, Bruschke AU, Jukema JW, van den Heuvel LP, Trijbels FJ, Boerma GJ, Verheught FW, Willems F, Blom HJ: Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997; 96: 2573–2577 [DOI] [PubMed] [Google Scholar]
- 23. Rees MM, Rodgers GM: Homocysteinemia: Association of a metabolic disorder with vascular disease and thrombosis. Thromh Res 1993; 71: 337–359 [DOI] [PubMed] [Google Scholar]
- 24. Kang SS, Wong PW, Norusis M: Homocysteinemia due to folate deficiency. Metabolism 1987; 36: 458–462 [DOI] [PubMed] [Google Scholar]
- 25. Franken DG, Boers GH, van den Heuvel LP Cruysberg JR, Trijbels FJ, Hamel BC: Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994; 14: 465–470 [DOI] [PubMed] [Google Scholar]